• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo.

作者信息

Teichmann J V, Ludwig W D, Thiel E

机构信息

Department of Hematology and Oncology, Universitätsklinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany.

出版信息

Recent Results Cancer Res. 1993;131:223-38. doi: 10.1007/978-3-642-84895-7_20.

DOI:10.1007/978-3-642-84895-7_20
PMID:8210642
Abstract
摘要

相似文献

1
Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo.人白血病细胞对同种异体和自体淋巴因子激活的杀伤细胞的敏感性及其在体外和体内通过将白血病靶细胞暴露于细胞毒性药物而增强。
Recent Results Cancer Res. 1993;131:223-38. doi: 10.1007/978-3-642-84895-7_20.
2
Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.人类白血病对同种异体和自体淋巴因子激活的杀伤细胞活性的敏感性：252份样本分析
Nat Immun. 1992 May-Jun;11(3):117-32.
3
In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.
Leukemia. 1994 May;8(5):724-8.
4
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.VLA - 6（CDw49f）是自体或异基因骨髓移植后自然杀伤细胞介导的细胞毒性中的一种重要黏附分子。
Exp Hematol. 1995 Dec;23(14):1530-4.
5
Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy.白细胞介素-2激活的MHC非限制性淋巴细胞在抗白血病活性及治疗中的作用
Leuk Lymphoma. 1992 May;7(1-2):15-28. doi: 10.3109/10428199209053598.
6
Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells.联合诱导白细胞介素-2/白细胞介素-15并不会进一步增强白细胞介素-15诱导的淋巴因子激活的杀伤细胞对人白血病/淋巴瘤细胞的细胞毒性。
Clin Immunol. 2005 Jun;115(3):240-9. doi: 10.1016/j.clim.2005.01.008.
7
Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.白细胞介素-7对自体和同基因骨髓移植受者在全身应用白细胞介素-2治疗前后淋巴细胞中淋巴因子激活的杀伤活性的诱导作用。
Exp Hematol. 1993 Sep;21(10):1371-8.
8
Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.白细胞介素2诱导的淋巴因子激活的杀伤细胞（LAK细胞）对人白血病的细胞毒性以及干扰素和肿瘤坏死因子对杀伤作用的增强。
Leuk Res. 1992;16(3):287-98. doi: 10.1016/0145-2126(92)90067-h.
9
In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.体内白细胞介素2诱导头颈部肿瘤患者颈淋巴结中淋巴因子激活的杀伤细胞和肿瘤细胞毒性T细胞的活化。
Cancer Res. 1990 Sep 1;50(17):5551-7.
10
Lymphokine-activated killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia.急性白血病患者的淋巴因子激活的杀伤细胞毒性及淋巴细胞亚群
Leuk Res. 1994 Nov;18(11):815-22. doi: 10.1016/0145-2126(94)90161-9.